Minkin Mary Jane
Department of Obstetrics and Gynecology, Yale University School of Medicine, New Haven, Connecticut, USA.
J Reprod Med. 2007 Feb;52(2 Suppl):165-8.
Increased awareness of the risk of cardiovascular disease (CVD) in postmenopausal women will aid clinicians in choosing the most appropriate hormone therapy (HT) for their patients. An antialdosterone-containing hormonal therapy offers postmenopausal women advantages beyond simply the relief of menopausal symptoms; drospirenone/estradiol therapy has a theoretical advantage for the modulation of postmenopausal cardiovascular target organ complications. Additionally, drospirenone/ estradiol therapy represents an attractive alternative to other forms of HT.
提高对绝经后女性心血管疾病（CVD）风险的认识，将有助于临床医生为患者选择最合适的激素疗法（HT）。含抗醛固酮的激素疗法为绝经后女性带来的益处不仅仅是缓解绝经症状；屈螺酮/雌二醇疗法在调节绝经后心血管靶器官并发症方面具有理论优势。此外，屈螺酮/雌二醇疗法是其他形式HT的一个有吸引力的替代方案。
